Researchers at ANRS conducted the first trial designed to assess the efficacy and safety of the new hepatitis treatment in sub-Saharan countries. PHOTO FILE | NATION
Scientists have come up with a new treatment for hepatitis C targeting resource-limited countries, especially those in sub-Saharan Africa.
According to Dr Karine Lacombe, an associate professor at Saint-Antrine Hospital, Inserm, France, preliminary results from a trial study by the French National Agency for Research on Aids and Viral Hepatitis (ANRS) show that direct-acting antivirals (DAAs) against hepatitis C can be effective in such countries.
